Characteristics and prognosis of patients with angiographic stent thrombosis: Comparison between drug-eluting and bare-metal stents

Archives of Cardiovascular Diseases

Volumn 101, Issue 4, 2008, Pages 220-225

  Le Feuvre, C ^a   Helft, G ^a   Cohen, S ^a   Batisse, J P ^a   Barthelemy O ^a   Collet, J P ^a   Beygui, F ^a   Choussat, R ^a   Montalescot, G ^a   Metzger, J P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Drug eluting stent; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ARTICLE; BALLOON DILATATION; CONTROLLED STUDY; DISEASE DURATION; DRUG ELUTING STENT; FEMALE; HEART LEFT VENTRICLE FAILURE; HUMAN; INTERMETHOD COMPARISON; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; STENT; THROMBOSIS; TREATMENT OUTCOME;

EID: 46249132144     PISSN: 18752136     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1875-2136(08)73696-9     Document Type: Article

References (24)

1. Serruys PW, Kutryk MJB, Ong ATL. Coronary-artery stents. N Engl J Med 2006;354:483-95.
2. Moreno R, Fernandez C, Hernandez R, et al. Drug-eluting stent thrombosis. Results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005;45:954-9.
3. Spaulding CS, Daermen J, Boersma E, et al. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:989-97.
4. Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:1030-9.
5. Mauri L, Hsieh W, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-9.
6. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus - and paclitaxel - eluting coronary stents. N Engl J Med 2007;356:998-1008.
7. Lagerqvist B, James SK, Sternestrand U, et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007;356:1009-19.
8. Park DW, Park SW, Lee SW, et al. Frequency of coronary arterial late angiographic stent thrombosis (LAST) in the first 6 months: outcomes with drug-eluting stents versus bare metal stents. Am J Cardiol 2007;99:774-8.
9. de Man FH, Stella PR, Nathoe H, et al. Stent thrombosis in real-world patients: a comparison of drug-eluting with bare metal stents. Neth Heart J 2007;15:382-6.
10. Campolo L, Pantaleo P, Barattoni MC, et al. RESTEM: a percutaneous coronary intervention 'real world' registry in the drug-eluting stent era. Coron Artery Dis 2007;18:653-62.
11. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2005;349:1315-23.
12. Regar E, Serruys PW, Bode C, et al. Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size. Circulation 2002;106:1949-56.
13. Cutlip DE, Baim DS, Kalon KL, et al. Stent thrombosis in the modern era. A pooled analysis of multicenter coronary stent clinical trials. Circulation 2001;103:1967-71.
14. Schofer J, Schluter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003;362:1093-9.
15. Karvouni E, Korovesis S, Katritsis DG. Very late thrombosis after implantation of sirolimus eluting stent. Heart 2005;91:e45.
16. Ong AT, McFadden EP, Reggar E, et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005;45;2088-92.
17. Wang F, Stouffer GA, Wawman S, et al. Late coronary stent thrombosis: early versus late stent thrombosis in the stent era. Catheter Cardiovasc Interventions 2002;55:142-7.
18. Farb A, Burke AP, Kolodgie FD, et al. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003;108:1701-6.
19. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis. Classification and implications for long-term outcome. Circulation 1999;100:1872-8.
20. Hayashi T, Kimura A, Ishikawa K. Acute myocardial infarction caused by thrombotic occlusion at a stent site two years after conventional stent implantation. Heart 2004;90:e26.
21. Ferrari E, Benhamou M, Cerboni P, et al. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 2005;45:456-9.
22. lakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting-stents. JAMA 2005;293:2126-30.
23. Machecourt J, Danchin N, Lablanche JM, et al. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched Cohort Registry. J Am Coll Cardiol 2007;50(6):501-8.
24. Jeremias A, Sylvia B, Bridges J, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004;109:1930-2.